Cosmetics Stakeholders Watching October For FDA Proposal On Allergen Labeling

Anna Benevente, director of the Product, Labeling and Ingredient Review Department at consultancy Registrar Corp, offers perspective on the US FDA’s overdue rulemaking proposal for fragrance allergen labeling on cosmetic products under MoCRA, as well as adverse event reporting compliance.

Fragrance label
• Source: Shutterstock

The US Food and Drug Administration may issue a proposed rule for fragrance allergens labeling under the Modernization of Cosmetics Regulation Act in October after missing the statutory June deadline, with expectations for a 1-2 year transition period before disclosures are required.

“All we know at this point is the proposed list is coming out in October potentially – that’s what was...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Ingredients & Safety

Different Name, Same Contamination, Recall Problems For US Homeopathic Nasal Spray Firm

Green Pharmaceuticals’ SnoreStop Nasal Spray, previously marketed as “NasoSpray,” still is available even though agency officials on multiple occasions for a month recommended a recall after an April inspection found “gross microbial contamination” in one lot.

Over The Counter: Exploring The Postbiotic Opportunity In Consumer Health, With Kerry’s Sonja Nodland

 
• By 

In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry. 

Kratom Industry Argues FDA Wants To Label All Products As Adverse Events Without Evidence

 

Week after publishing safety alert about OPMS Black Liquid Kratom “linked to serious adverse health effects, including death,” FDA announced market research “to understand and characterize emergent risk/safety and perceived benefits reportedly linked to kratom and psychedelics.” But it withdrew the study 10 days later.

Evidence Challenging Safety Of Maternal Use Of Acetaminophen Amounts To ‘Speculation’ – Court

 

Height of plaintiff attorney’s argument to present evidence which would prompt speculation by a jury was request to parse research by Kenvue’s lead expert, who coordinated the International Consensus Statement on ADHD by the World Federation of ADHD, where he’s president.

More from HBW Insight

data

Type:DataArticle | Publication:HBW | Section:Health | Paywall:Premium — Article containing all Composer content for testing (Do not update)

 
• By 

To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.

Test: PDF Link Lifetime

Description description

headline test

description